AstraZeneca PLC (Brazil) Analysis
| A1ZN34 Stock | BRL 67.34 0.19 0.28% |
AstraZeneca PLC is overvalued with Real Value of 57.56 and Hype Value of 69.46. The main objective of AstraZeneca PLC stock analysis is to determine its intrinsic value, which is an estimate of what AstraZeneca PLC is worth, separate from its market price. There are two main types of AstraZeneca PLC's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect AstraZeneca PLC's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of AstraZeneca PLC's stock to identify patterns and trends that may indicate its future price movements.
The AstraZeneca PLC stock is traded in Brazil on Sao Paulo Exchange, with the market opening at 10:00:00 and closing at 18:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Brazil. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and AstraZeneca PLC's ongoing operational relationships across important fundamental and technical indicators.
AstraZeneca |
AstraZeneca Stock Analysis Notes
The book value of the company was presently reported as 11.96. The company has Price/Earnings To Growth (PEG) ratio of 0.68. AstraZeneca PLC last dividend was issued on the 11th of August 2022. For more info on AstraZeneca PLC please contact Marc Dunoyer at 44 20 3749 5000 or go to https://www.astrazeneca.com.AstraZeneca PLC Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. AstraZeneca PLC's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding AstraZeneca PLC or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| AstraZeneca PLC generated a negative expected return over the last 90 days |
AstraZeneca Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 1.13 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AstraZeneca PLC's market, we take the total number of its shares issued and multiply it by AstraZeneca PLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.AstraZeneca Profitablity
AstraZeneca PLC's profitability indicators refer to fundamental financial ratios that showcase AstraZeneca PLC's ability to generate income relative to its revenue or operating costs. If, let's say, AstraZeneca PLC is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, AstraZeneca PLC's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of AstraZeneca PLC's profitability requires more research than a typical breakdown of AstraZeneca PLC's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.07 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.19 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.19. Technical Drivers
As of the 11th of December 2024, AstraZeneca PLC shows the Risk Adjusted Performance of (0.03), standard deviation of 2.42, and Mean Deviation of 1.67. AstraZeneca PLC technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.AstraZeneca PLC Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. AstraZeneca PLC middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for AstraZeneca PLC. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
AstraZeneca PLC Predictive Daily Indicators
AstraZeneca PLC intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of AstraZeneca PLC stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
AstraZeneca PLC Forecast Models
AstraZeneca PLC's time-series forecasting models are one of many AstraZeneca PLC's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary AstraZeneca PLC's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding AstraZeneca PLC to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Complementary Tools for AstraZeneca Stock analysis
When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |